Neuraxis, INC (NRXS) stock
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.87+0.26 (+5.64%)
Close on Nov 18, 2026Market cap $61.16MP/E –Yield –
Neuraxis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Neuraxis's operating cash flow for the twelve months ending Jun 30, 2026 was -$5.62M. For fiscal 2025 it was -$6.43M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.43M | – |
| FY2024 | Dec 31, 2024 | -$6.10M | – |
| FY2023 | Dec 31, 2023 | -$6.69M | – |
| FY2022 | Dec 31, 2022 | -$2.30M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.03M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.23M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.43M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.47M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.60M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.76M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.39M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.62M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.33M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.63M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.82M | – |
| Q2 FY2023 | Jun 30, 2023 | -$625.23K | – |
| Q1 FY2023 | Mar 31, 2023 | -$622.91K | – |
| Q4 FY2022 | Dec 31, 2022 | -$214.32K | – |
| Q3 FY2022 | Sep 30, 2022 | -$911.79K | – |
See a number that looks wrong?